{"id":"W2897161734","doi":"10.1002/cncr.31595","title":"Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2018,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre; University of Ottawa; Health Sciences Centre; University of Alberta; Queen Elizabeth II Health Sciences Centre; McMaster University; London Health Sciences Centre; Princess Margaret Cancer Centre","funders":"Foundation Medicine; Novartis Pharma; Genentech; Ipsen; Celldex Therapeutics; Astellas Pharma; Eisai; National Comprehensive Cancer Network; Sanofi; Exelixis; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Ipilimumab; Internal medicine; Oncology; Clear cell renal cell carcinoma; Retrospective cohort study; Carcinoma; Cancer; Gastroenterology; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001927469,0.0001978495,0.0006966906,0.001203775,0.0002198947,0.0009702062,0.0005303551,0.000303313,0.0007046121],"category_scores_gemma":[0.005640849,0.0000859767,0.0005428644,0.002861337,0.0001356835,0.0004837483,0.0007725132,0.000332597,0.0001458737],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007421786,"about_ca_system_score_gemma":0.0007225055,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00820078,"about_ca_topic_score_gemma":0.008634184,"domain_scores_codex":[0.9982136,0.0005014553,0.0003101179,0.0003661581,0.0004830566,0.000125664],"domain_scores_gemma":[0.9955805,0.0008133947,0.002474507,0.0002169026,0.0005649773,0.0003497958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003992271,0.00002992239,0.9948511,0.00009499019,0.0002663436,0.00003304506,0.00003604115,0.0001932931,0.00006299087,0.00002697795,0.0009692553,0.003036806],"study_design_scores_gemma":[0.0001000107,0.0001177071,0.9962406,0.00005097429,0.000277104,0.0003536538,0.0001756984,0.0008094891,0.0001664282,0.00002836595,0.001670666,0.000009415367],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9779473,0.002785896,0.000139671,0.0002807296,0.00001390532,0.00005637627,0.01744086,0.00001266397,0.001322628],"genre_scores_gemma":[0.9834054,0.0006693095,0.0001349198,0.0001043174,0.0000181954,0.00004612276,0.0155157,0.000004524815,0.0001016647],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00820078,"threshold_uncertainty_score":0.01630604,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02731998789822587,"score_gpt":0.2602327787762104,"score_spread":0.2329127908779846,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}